Haochen Medical: Short-term financial management business management system
Haochen Medical Technology Co., Ltd.
Short-term financial management business management system
Chapter 1 General Provisions
Article 1 In order to regulate the short-term financial transactions of Haochen Medical Technology Co., Ltd. (hereinafter referred to as the "Company") and the company's holding subsidiaries, and ensure the safety of the company's funds and property, this system is formulated in accordance with the provisions of the Shenzhen Stock Exchange's "Stock Listing Rules", "Measures for the Administration of Information Disclosure of Listed Companies" and the "Articles of Association".
Article 2 The "short-term financial management business" referred to in this system refers to the financial management behavior in which a company uses its own funds to purchase and sell capital-guaranteed income financial products (excluding financial products with stocks as the main investment types) or invest in fixed-income securities (excluding stocks, securities investment funds, unsecured bonds and other marketable securities and their derivatives) with its own funds in order to make full use of idle funds, improve fund utilization, and increase company income, and the investment period does not exceed one year.
Article 3 The principles for companies to engage in short-term financial management transactions are:
(1) Short-term financial management transaction funds are the company’s idle funds, and raised funds may not be used to directly or indirectly purchase financial products, and their use will not affect the company’s normal production and operation activities and investment needs;
(2) The subject matter of the short-term financial management transaction is a capital-guaranteed fixed-income product or a capital-guaranteed income-increasing product and its expected return is higher than the RMB time or demand deposit interest rate in the same period.
(3) When the company conducts short-term financial management business, it is only allowed to conduct transactions with financial institutions with legal business qualifications, and is not allowed to conduct transactions with informal institutions.
(4) Financial product accounts must be established in the name of the company, and no other person’s account may be used to operate financial products.
Chapter 2 Management Organization of Short-term Financial Management Business
Article 4 The company’s shareholders’ meeting is the final approval authority for the company’s short-term financial management business.
Article 5 According to the relevant provisions of the "Major Operation and Investment Decision Management System of Haochen Medical Technology Co., Ltd." and the "Articles of Association", the approval authority for the company's short-term financial management business is stipulated as follows:
- For a single business, the chairman of the company shall make a decision within the scope of less than 10% (excluding 10%) of the company's latest audited net assets and the amount does not exceed 10 million yuan.
Haochen Medical Short-term Financial Management Business Management System
For investments in similar financial products for 12 consecutive months, the chairman has the right to make decisions within the scope of not exceeding 10% (exclusive of 10%) of the company's latest audited net assets and the amount not exceeding 10 million yuan.
If the amount of financial management transactions (including liabilities and expenses) accounts for more than 10% of the company's latest audited net assets, and the absolute amount exceeds 10 million yuan, it should be reported to the company's board of directors for review and approval.
If the profits generated by financial management account for more than 10% of the company's latest audited net profit, and the absolute amount exceeds 1 million yuan, it should be reported to the company's board of directors for review and approval.
If the amount of financial management transactions (including liabilities and expenses) accounts for more than 50% of the company's latest audited net assets, and the absolute amount exceeds 50 million yuan, it should be submitted to the shareholders' meeting for review after being reviewed and approved by the board of directors.
If the profits generated by financial management account for more than 50% of the company's latest audited net profit, and the absolute amount exceeds 5 million yuan, it should be submitted to the shareholders' meeting for review after being reviewed and approved by the board of directors.
The financial management business mentioned in this system shall be calculated based on the amount incurred and shall be calculated based on the cumulative amount incurred for twelve consecutive months. If financial management business occurs on a rolling basis for twelve consecutive months, the highest balance during that period shall be the transaction amount, and the provisions of this article shall apply.
Article 6 The company’s finance department is the specific department responsible for short-term financial management business. The Finance Department is responsible for conducting content review and risk assessment of short-term financial management business based on the company's financial status, cash flow status, interest rate changes, etc., formulating financial management plans and submitting them to the general manager for review, raising funds required for short-term financial management business, handling relevant procedures for short-term financial management business, handling financial business accounting on a monthly basis, and archiving and keeping relevant files. The person in charge of finance is the first responsible person.
Article 7 The company’s audit department is the supervisory department for short-term financial management business. The audit department conducts pre-review, in-process supervision and post-audit on the company's short-term financial management business. The audit department is responsible for reviewing the approval status, actual operation status, fund usage and profit and loss status of financial management business, supervising the Finance Department to conduct accounting processing in a timely manner, and verifying the accounting processing status. The manager of the audit department (or the first person in charge of the department) is the first responsible person.
Chapter 3 Short-term Financial Management Business Implementation Process
Article 8 Operational procedures for short-term financial management business:
(1) The Finance Department conducts a feasibility study on the short-term financial management business based on the company's financial situation and cash flow, combined with interest rate changes and short-term financial management targets and other factors, and submits the financial management plan to the company's general manager for review;
Haochen Medical Short-term Financial Management Business Management System
(2) After review and written consent by the general manager of the company, the short-term financial management business will enter the implementation stage or the next approval stage until implementation based on the amount and the approval authority of the chairman, board of directors and shareholders' meeting;
(3) During the operation of short-term financial management business, the Finance Department shall make timely settlements with financial institutions in accordance with the terms agreed in the agreement signed with the financial institution. When interest rates fluctuate drastically, the finance department should conduct timely analysis and notify the company's general manager of the relevant information. Before the 5th of every month, the Finance Department will report the profit and loss of short-term financial management business to the general manager and the audit department;
(4) After the short-term financial management business expires, the Finance Department should take timely measures to recover the principal and interest of the short-term financial management business and conduct relevant accounting processing.
Article 9 Information confidentiality measures for short-term financial management business:
(1) The applicants, reviewers, approvers, operators and fund managers of the financial management business are independent of each other, and the audit department is responsible for the full supervision;
(2) Relevant staff of the company and relevant personnel of financial institutions must abide by the confidentiality system and shall not disclose the company's financial management plan, transaction status, settlement situation, capital status and other information related to the company's financial management business without permission.
Chapter 4 Supplementary Provisions
Article 10 This system applies to the company and its branches.
Article 11 The short-term financial management business of the company's holding subsidiaries can be implemented with reference to this system.
Article 12 The right to interpret this system belongs to the company's board of directors.
Article 13 This system shall be implemented after approval by the company's board of directors. If the relevant provisions of this system conflict with the relevant laws, regulations, rules and the Articles of Association that have been revised in accordance with legal procedures in the future, they shall be implemented in accordance with the provisions of the relevant laws, regulations, rules and the Articles of Association. The board of directors shall revise this system in a timely manner.
Board of Directors of Haochen Medical Technology Co., Ltd.
December 12, 2025